drugset / Trial / NCT00447603

A Study of Losartan Compared to Losartan/HCTZ in Pediatric Patients With Hypertension (0954A-327)

NCT00447603

Phase 3 Terminated 40 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to test the safety and effectiveness of Losartan as compared to Losartan/HCTZ in pediatric patients (6 to 17 years) with high blood pressure.

Timeline

Start
2007-05-24
Primary completion
2007-10-22
Completion
2007-10-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrochlorothiazide Unknown 12.5 mg Oral
Comparator Losartan Other / unclassified 50 mg Oral
Comparator Losartan Other / unclassified 100 mg Oral

Indications